A device to reduce steroid use in skin lymphoma
Part of Cancer, Skin clinical trials.
This study tests a device that may help reduce the need for steroid creams in people with cutaneous T-cell lymphoma (a type of skin lymphoma). It might help with itching and skin reactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to understand and sign a consent form.
- You must have a diagnosis of cutaneous T-cell lymphoma (a type of skin lymphoma).
- You must have at least one of: severe itching, a skin reaction to a specific gel called mechlorethamine, a rash from chemotherapy or immunotherapy, or heavy reliance on topical steroids for symptom relief.
- You cannot be currently receiving radiation therapy.
- You cannot be currently taking oral steroids (steroids by mouth).
- You must be able to apply topical creams or gels to your skin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called PTX 100 for people with cutaneous T-cell lymphoma (CTCL) that has come back after at least two prior treatments. It aims to see if PTX 100 can help shrink tumors or slow the disease.
This study collects stored tissue samples (from skin or other needed procedures) from people with CTCL, Sézary syndrome, or lymphomatoid papulosis, especially when you are starting or changing treatment. It’s meant to help researchers learn more about these illnesses and may support future research.
This trial tests a treatment called photopheresis to treat early-stage mycosis fungoides, a type of skin lymphoma. It may help reduce or control skin patches or plaques that have not responded well to standard treatments.
This trial tests whether a medicated skin gel (StrataXRT) can better prevent painful skin rash (“acute dermatitis”) in people with head and neck cancer who receive chemotherapy and radiation at the same time. If you’re eligible, you may get the study skin product and help doctors find a safer, more comfortable way to protect the skin during treatment.
This trial is testing new treatment plans based on the genetic type of your cutaneous T-cell lymphoma (CTCL). It's for people whose CTCL did not respond well to standard skin treatments.
This trial tests a tiny device placed directly into skin lymphoma spots to help identify which “candidate” drugs could work. It’s mainly aimed at people with measurable skin involvement from T-cell lymphoma, after they stop certain treatments for a set time.
Hear when a new CTCL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.